Fabrication and Evaluation of Solid Self Emulsifying Drug Delivery System of Dolutegravir sodium by using Adsorption to Solid Carrier Techniques
-
Published:2022-09-28
Issue:
Volume:
Page:4158-4165
-
ISSN:0974-360X
-
Container-title:Research Journal of Pharmacy and Technology
-
language:en
-
Short-container-title:RJPT
Author:
A. Deokule Hemant1, S. Pimple Smita1, C. Mahajan Kiran1, D. Chaudhari Praveen1
Affiliation:
1. Department of Pharmaceutics, P.E. Society’s Modern College of Pharmacy, Nigdi - 411044 Dist – Pune, Maharashtra, India.
Abstract
The objective of this work was to design and characterize liquid and solid self-emulsifying drug delivery systems (SEDDS) for poorly soluble Dolutegravir Sodium. To optimize the composition of liquid Dolutegravir Sodium-SEDDS, solubility tests, pseudoternary phase diagrams, emulsification studies and other in vitro examinations (thermodynamic stability, droplet size and zeta potential analysis) were performed. The central composite design was employed to optimize the formulation variables, Capmul MCM (oil), Tween 80 (surfactant) and Propylene glycol (co-surfactant). Liquid self-emulsifying drug delivery system was appraised for determination of self emulsifying time, globule size and drug release. TEM study confirmed the uniform oil globules of the optimized liquid formulation. The optimized liquid formulation was formulated into free-flowing powder (S-SEDDS) by adsorption on the materials like Aerosil 200, Neusilin US2 and compressed into tablets. The solid state characterization of S-SEDDS powder was performed by using DSC, PXRD and SEM to investigate the physical nature of the drug. Further, the accelerated stability studies for 6 months revealed that S-SEDDS of Dolutegravir Sodium was found to be stable without any significant change in physico-chemical properties. S-SEDDS of Dolutegravir Sodium with improved dissolution profile was successfully prepared by using Neusilin US2 as an adsorbent carrier as compared to marketed sample.
Publisher
A and V Publications
Subject
Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference32 articles.
1. Lipinski, C.A. Poor aqueous solubility-An industry wide problem in ADME screening. Am. Pharm. Rev. 2002, 5, 82–85. 2. Rao, B.P.; Baby, B.; Durgaprasad, Y.; Rames, K.; Rajarajan, S.; Keerthi, B.; Sreedhar, C. et al Formulation and evaluation of SMEDDS with CapmulMCMfor enhanced dissolution rate of valsartan. RGUHS J. Pharm. Sci. 2013, 3, 33–40. 3. Patel, A.R.; Vavia, P.R. et al Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J. Incl. Phenom. Macrocycl. Chem. 2006, 56, 247–251. 4. Vaculikova, E.; Placha, D.; Pisarcik, M.; Peikertova, P.; Dedkova, K.; Devinsky, F.; Jampilek, J. et al Preparation of risedronate nanoparticles by solvent evaporation technique. Molecules 2014, 19, 17848–17861. 5. Karim, F.T.; Kalam, A.; Anwar, R.; Miah, M.M.; Rahman, S.; Islam, A. et al Preparation and evaluation of SEDDS of simvastatin by in vivo, in vitro and ex vivo technique. Drug Dev. Ind. Pharm. 2014, 20, 1–5.
|
|